-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

616. Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Poster III

Symposia: Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Naval Daver, MD1, Kyoo Hyung Lee, MD, PhD2*, Yunsuk Choi, MD, PhD2, Pau Montesinos, PhD, MD3*, Brian A. Jonas, MD, PhD4, Martha L. Arellano, MD5, Uma Borate, MD6, Justin M. Watts, MD7, Paul B. Koller, MD8, Chul Won Jung, MD9, Sang Kyun Sohn10*, Amir T. Fathi, MD11, Pankit Vachhani, MD12*, Nikolai A. Podoltsev, MD, PhD13, Olga Salamero, MD14*, Sung-Soo Yoon, M.D., Ph.D.15, Jeong-Ok Lee, MD16, Gabriel N Mannis, MD17, Shuhying Tan, FRACP, FRCPA, MBBS18*, Sudipto Mukherjee, MD, PhD, MPH19, Harry Erba, MD, PhD20*, Ho-Jin Shin, MD21*, Uwe Platzbecker, MD22, Mar Tormo, MD23, Eric Tam, MD24, Leanne Berkahn, MD25, Teresa Bernal26*, Donna Nguyen Haney27*, Jia Hu, PhD27*, Ranjeet Kumar Sinha, PhD27*, Nawazish Khan, MD, MS27*, Vivian Costa Victory, PhD27*, William G. Rice, PhD27 and Rafael Bejar, MD, PhD27

1University of Texas MD Anderson Cancer Center, Houston, TX
2Asan Medical Center, Seoul, Korea, Republic of (South)
3Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
4UC Davis Comprehensive Cancer Center, Davis, CA
5Emory University, Atlanta, GA
6The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH
7University of Miami, Miller School of Medicine, Miami, FL
8Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Samsung Medical Center, Seoul, South Korea, KOR
10Kyungpook National University Hospital, Daegu, Korea, Republic of (South)
11Massachusetts General Hospital, Boston, MA
12University of Alabama at Birmingham, Birmingham, AL
13Yale School of Medicine, New Haven, CT
14Hematology Department, University Hospital Vall d’Hebron, Barcelona, Spain
15Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
16Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
17Stanford, Stanford Cancer Center, Palo Alto, CA
18St. Vincent's Hospital, Melbourne, Australia
19Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
20Duke Cancer Institute, Durham, NC
21Pusan National University Hospital, Busan, Korea, Republic of (South)
22Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany
23INCLIVA Research Institute, University Clinical Hospital, Valencia, Spain
24USC Norris Comprehensive Cancer Center, Los Angeles, CA
25Aukland City Hospital, Auckland, New Zealand
26Hospital Universitario Central de Asturias, Oviedo, Spain
27Aptose Biosciences, San Diego, CA

Prateek Pophali, MBBS1, Giulia Cheloni, PhD2*, Richard M. Stone, MD3, Kai W Wucherpfennig, MD, PhD4*, Aric C. Hall, MD5*, Amir T. Fathi, MD6, Lina Bisharat, MS2*, Emma K Logan7*, Yiwen Liu, MS8*, Donna S. Neuberg, ScD9, Malgorzata McMasters, MD10, Jessica Liegel, MD2, Jacqueline S. Garcia, MD11, Daniel J. DeAngelo, MD, PhD11, Michele Narcis10*, Dina Stroopinsky, PhD12*, Pavania Elavalakanar, MSc, BSc7*, Ioannis S Vlachos, PhD7*, Ilene A. Galinsky, MSN, ANP-C11, Jason Pyrdol13*, Georges Chedid, MD14*, Dimitra Karagkouni, PhD15*, Shivani Nanda16*, Kathrine S Rallis, MBBS, MSc17, Isabella Saldarriaga, BS18*, Hazal Toros, MS2*, Haitham Abdelhakim, MD19, Amelia Langston, MD20, Joseph P. McGuirk, DO21, Donald Kufe, MD4*, David Avigan, MD18 and Jacalyn Rosenblatt, MD18

1Beth Israel Deaconess Medical Center, FRAMINGHAM, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
5Department of Medicine Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin–Madison, Madison, WI
6Massachusetts General Hospital, Boston, MA
7Beth Israel Deaconess Medical Center, Boston, MA
8Data Science, Dana-Farber Cancer Institute, Boston, MA
9Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
10Beth Israel Deaconess Medical Center, Boston
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Takeda Oncology, Boston
13Dana-Farber Cancer Insitute, Boston, MA
14Mount Auburn Hospital, Cambridge
15Department of Pathology, Cancer Research Institute, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
16Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA
17Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
18Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
19Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
20Emory University, Winship Cancer Institute, Atlanta, GA
21Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Amanda F. Cashen, MD1, Monzr M. Al Malki, MD2, Don A. Stevens, MD3, Lori Muffly, MD4, Natasha Edwin, MD5, Edward Abadir, PhD, MBBS, FRACP, FRCPA6*, Peter T. Tan, MBBS7, Sandrine Niyongere, MD8, Ashish Bajel, MBBS, FRACP, FRCPA9, Laura Arthur, PhD10*, Nitin Mahajan, PhD, MSc, MS11*, Ben Capoccia, PhD10*, Tom Leedom12*, Basia Muz, PhD, MSc13*, Kristann Magee13*, Ouiam Bakkacha, MD10*, Justo L. Gonzalez, MD13*, Deborah Masters, RN MS13*, Stephen Moran14*, Eileen McNulty, MS11*, Angela Pannunzio13*, Jayakumar Vadakekolathu, PhD15*, Tony Wu, PhD16*, Maria del Rosario, BA CCRP13*, Preeta Dasgupta, PhD17*, Michael Munroe, BS PhD13*, Laura Simpson, PhD18*, Melissa M Berrien-Elliott, PhD19*, John Muth, MSc14*, Sergio Rutella, MD, PhD, FRCPath15, Jan K Davidson-Moncada, MD, PhD, MSc20 and Todd A Fehniger21

1Washington University School of Medicine, Saint Louis, MO
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Norton Cancer Institute, Norton Health Care, Louisville, KY
4Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
5Providence Cancer Center, Portland, OR
6Royal Prince Alfred Hospital, Camperdown, NSW, Australia
7Royal Perth Hospital, Perth, Australia
8Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD
9Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia
10Wugen, Saint Louis, MO
11Wugen, St Louis, MO
12Wugen, San Diego
13Wugen, St Louis
14Wugen, St. Louis, MO
15John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
16Wugen, St. Louis
17Wugen, San Diego, CA
18Wugen, Tarrytown, NY
19St Louis University, St Louis
20Wugen, Washington, DC
21Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Sameem Abedin, MD1, Guru Subramanian Guru Murthy, MBBS2, Mehdi Hamadani, MD3, Laura C. Michaelis, MD2, Karen-Sue Carlson, MD, PhD4, Lyndsey Runaas, MD5*, Katelyn Gauger6*, Avinash Desai7*, Mary Chen7, Patrik Brodin7*, Kate L Li, PhD7*, Mojisola Rotibi7*, Umar Sayeed, MS8*, Alexandra M. Harrington, MD, MT(ASCP)9 and Ehab L. Atallah, MD2

1Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
5Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
6Medical College of Wisconsin, MILWAUKEE, WI
7Actinium Pharmaceuticals, New York, NY
8Actinium Pharmaceuticals, New York
9Medical College of Wisconsin, Milwaukee, WI

Maria L Amaya, MD, PhD1, Christine M. McMahon, MD2, Marc Schwartz, MD3, Jonathan Gutman, MD2, Andrew Kent, MD, PhD2, Diana Abbott, PhD4, Connor Sohalski2*, Jessica Dell-Martin2*, Ayele Belachew2*, Brett M Stevens, PhD, BS5*, Craig T Jordan, PhD5 and Daniel A Pollyea, MD3

1University of Colorado, Aurora, CO
2Division of Hematology, University of Colorado, Aurora, CO
3Division of Hematology, University of Colorado, Denver, CO
4Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
5Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO

Lin Song1*, Junyuan Qi, MD1*, Zhenzhen Wang, MD1*, Xiaoxia Li1*, Sa Xiao2*, Hai Zhu3*, Yi Zhu3* and Jianxiang Wang, MD1

1Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China
2Sichuan Biokin Pharmaceuticals Co.,Ltd., Chengdu, China
3Systimmune., Inc., Redmond, WA

Richard M Stone, MD1, Daniel J. DeAngelo, MD, PhD1, Anthony G. Letai2, Ilene A. Galinsky, MSN, ANP-C1, Howard Weiner3*, Austen Halpin1*, Lexi Noyes1*, Hunter Smith1*, Carter Lombardi1*, Rebecca Leonard1*, Geoffrey Fell1*, Yael Flammand1*, Jeremy Ryan, MS4*, Marina Konopleva5, Martha Wadleigh, MD1, Maximilian Stahl, MD1, Evan Chen, MD6*, Virginia O. Volpe, MD1, Eric S. Winer, MD1,7, Jacqueline S. Garcia, MD1, Marlise R. Luskin, MD1 and Anand Ashwin Patel, MD8

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
3Harvard Medical School, Boston, MA
4Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston
7Department of Medical Oncology, Dana Farber Cancer Institute, Boston
8Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Caitlin R Rausch, PharmD1*, Emmanuel Almanza-Huante, MD1*, Wei-Ying Jen, MD, FRCPath, MA1*, Guillermo Montalban-Bravo, MD1, Farhad Ravandi, MBBS2, Kelly S. Chien, MD3, Nicholas J. Short, MD1, Naval Daver, MD4, Courtney D. DiNardo, MD, MSc1, Abhishek Maiti, MBBS1, Joseph E. Jabbour5*, Ghayas C. Issa, MD1, Guillermo Garcia-Manero, MD1, Hagop M. Kantarjian, MD1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson, Houston, TX
4MD Anderson Cancer Center, Houston, TX
5Department of Leukemi, The University of Texas MD Anderson Cancer Center, Houston, TX

Musa Yilmaz, MD1*, Muharrem Muftuoglu, MD2, Nicholas J. Short, MD1, Sanam Loghavi, MD3, Tapan M. Kadia, MD1, Courtney D. DiNardo, MD, MSc4, Gautam Borthakur, MD2, Naveen Pemmaraju, MD5, Yesid Alvarado Valero, MD1, Abhishek Maiti, MBBS6, Marina Konopleva7, Lucia Masarova, MD1, Guillermo Montalban-Bravo, MD1, Carissa Jurisprudencia8*, Allison Pike, RN1*, Keyur P. Patel, MBBS, PhD3, Guilin Tang, MD, PhD3*, Jairo Matthews, BA9*, Steven M. Kornblau, MD1, Elias Jabbour, MD10, Guillermo Garcia-Manero, MD1, Koichi Takahashi, MD, PhD11, Michael Andreeff, MD, PhD2, Farhad Ravandi, MBBS12, Hagop M. Kantarjian, MD8 and Naval Daver, MD13

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
6Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
7Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
8The University of Texas MD Anderson Cancer Center, Houston, TX
9The University of Texas at MD Anderson Cancer center, Houston, TX
10Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
11Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
13MD Anderson Cancer Center, Houston, TX

Anthony S. Stein, MD1, Jianying Zhang, PhD2*, Lucy Y. Ghoda3,4*, Marjorie Robbins, PhD, MSc, BSc1,5*, Cindy Croslin, FNP-C1*, Banafsheh Sinaki, MD1,6*, Ahmed Aribi, MD7*, Amanda Blackmon, DO, MS8*, Hoda Pourhassan, MD1, Brian J. Ball, MD1, Ibrahim Aldoss, MD1, Ryotaro Nakamura, MD9, Monzr M. Al Malki, MD1, Karamjeet S Sandhu, MD1 and Guido Marcucci3,10

1Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Beckman Research Institute, Duarte, CA
3Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA
4Department of Research Business Operations, City of Hope National Medical Center, Duarte, CA
5Department of Clinical Translational Project Development, City of Hope National Medical Center, Duarte, CA
6Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
7Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
8Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
9Hematology and HCT, City of Hope National Medical Center, Duarte, CA
10Department of Hematologic Malignancies Translational Science, Duarte, CA

Mika Kontro, MD, PhD1,2, Anthony S. Stein, MD3, Marja Pyörälä, MD4*, Johanna Rimpiläinen, MD5*, Timo Siitonen, MD, PhD6*, Jenna H Rannikko7*, Jesper Mickos7*, Rita Turpin, PhD7*, Milja Hakoniemi7*, Birge Berns, MD8*, Sofia Aakko, PhD8*, Inka Pawlitzky, PhD9*, Maija Hollmén10*, Amer M. Zeidan, MD11 and Naval Daver, MD12

1Helsinki University Hospital and University of Helsinki, Helsinki, FIN
2Foundation for the Finnish Cancer Institute, Helsinki, Finland
3City of Hope National Medical Center, Duarte, CA
4Kuopio University Hospital, Kuopio, FIN
5Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
6Department of Hematology, Oulu University Hospital, Oulu, Finland
7University of Turku, Turku, Finland
8Faron Pharmaceuticals, Turku, Finland
9Faron, Turku, Finland
10MediCity Research Laboratory, Department of Microbiology and Immunology, University of Turku, Turku, Finland
11Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
12MD Anderson Cancer Center, Houston, TX

Naval Daver, MD1, Naveen Pemmaraju, MD2, Mikkael A. Sekeres, MD3, Amir T. Fathi, MD4, Andrew A. Lane, MD, PhD5,6, Anna Compagnoni7*, Ira Gupta, MD8, Alessandra Tosolini8*, Jessica Garzon, PharmD8* and Hagop M. Kantarjian, MD9

1Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
3Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
4Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA
7Menarini Group, Florence, Italy
8Menarini Group, New York, NY
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Ghayas C. Issa, MD1, Alexander J. Ambinder, MD, MPH2, Wenbin Xiao, MD, PhD3, Scott Manalis, PhD4*, Alex K Shalek, PhD5*, Lukasz P. Gondek, MD, PhD6, Alex Kentsis, MD, PhD7, Nicholas J. Short, MD1, Naval Daver, MD8, Jing Ning, PhD9*, Lianchun Xiao10*, Michael Hemann, PhD11*, Ken Chen, PhD12*, Keyur P. Patel, MD, PhD13*, Pavan Bachireddy, MD14, Andrew A. Lane, MD, PhD15, Marina Konopleva16, Omar Abdel-Wahab, MD17, Jeffrey J. Molldrem, MD18, Ross L Levine, MD19, Mark J. Levis6, Richard M Stone, MD15, Michael Andreeff, MD, PhD20, Farhad Ravandi, MBBS21, Aaron D. Goldberg22 and Jacqueline S. Garcia, MD15

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
3Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Massachusetts Institute of Technology, Cambridge, MA
5Institute for Medical Engineering & Science and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA
6Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
7Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
8MD Anderson Cancer Center, Houston, TX
9The University of Texas M.D. Anderson Cancer Center, Houston, TX
10Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston
11David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
12Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
13Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
14Department of Hematopoietic Biology & Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
15Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
16Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
17Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
18Departments of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
19Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
20Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
21Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
22Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Elisabeth Salzer, MD, PhD1*, Janine Stutterheim, MD, PhD2, Branko Cuglievan, MD3, Blake E. Tomkinson, PhD, MBA4, Mollie Leoni, MD5*, Harm Van Tinteren6,7*, Alwin D.R. Huitema6*, Marieke Willemse8*, Gwen L Nichols, MD9, Francisco Bautista10*, Sarah K Tasian, MD11, Todd M Cooper, DO12 and Christian Zwaan13

1St Anna Hospital, Vienna, AL, AUT
2prinsesmaximacentrum, Utrecht, Netherlands
3Division of Pediatrics, MD Anderson Cancer Center, Houston, TX
4Kura Oncology, Cambridge, MA
5Kura Oncology, Inc., San Diego, CA
6Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7Princess Máxima Center, Utrecht, Netherlands
8Erasmus MC, Rotterdam, Netherlands
9The Leukemia & Lymphoma Society, Rye Brook, NY
10Princess MáXima Centrum, Utrecht, NLD
11Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
12Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA
13Prinses Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands

Alexandra McLean Stevens, MD1, Maureen M. O'Brien, MD2, Xiaowei Liu, MS3*, Charles G Minard4*, Olga Militano, PharmD3*, Joel M Reid5*, Shyamala Navada, MD6*, Todd M Cooper, DO7, Sarah K Tasian, MD8, Elizabeth Fox, MD9* and Brenda J. Weigel, MD, MSc10

1Baylor College of Medicine/ Texas Children's Hospital, Houston, TX
2Colorado Children's Hospital and the University of Colorado School of Medicine, Aurora, CO
3Children's Oncology Group, Monrovia, CA
4Baylor College of Medicine, Houston, TX
5Mayo Clinic, Rochester, MN
6Executive Medical Director, Geron, Foster City, CA
7Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA
8Division of Oncology & Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
9St. Jude Children's Research Hospital, Memphis, TN
10University of Minnesota, Minneapolis, MN

Aditi Shastri, MD1, Mendel Goldfinger1*, Ioannis Mantzaris, MD2, Guillermo Garcia-Manero, MD3, Tapan M. Kadia, MD4, Jing Ning, PhD5*, Balda Tirone, MHA2*, Rikin Gandhi6*, Farhad Ravandi, MBBS7, Naveen Pemmaraju, MD8, Guillermo Montalban-Bravo, MD4, Annemarie Munoz, RN6*, Michelle Golez3*, Lianchun Xiao9*, Kith Pradhan, PhD10*, Karen Fehn, RN, BSN11*, Lamisha Shah12*, Hui Zhang6*, Samarpana Chakraborty13, Eric J. Feldman, MD2*, Nicholas J. Short, MD4, Jayastu Senapati, MD, DM, MBBS4, Dennis L Cooper, MD11, Alejandro Sica, MD14*, Noah Kornblum, MD11, Lauren Shapiro, MD11, Nishi Shah, MBBS, MPH11, Susan MacIntyre15*, Ulrich Steidl16, Amit Verma, MD16, Kira Gritsman, MD, PhD17, Andrew Denker, MD, PhD15*, Marina Konopleva18 and Naval Daver, MD19

1Hematology/Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
2Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
3M.D Anderson Cancer Center, Houston
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Montefiore Medical Center/Albert Einstein College of Medicine, Bronx
7Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
9Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston
10Montefiore Einstein Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
11Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
12Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
13Albert Einstein College of Medicine, New York, NY
14Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
15Flamingo Therapeutics, Leuwen, Belgium
16Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
17Albert Einstein College of Medicine, Bronx, NY
18Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
19MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH